Dave Rosa is president, leading Intuitive’s core business and driving product and commercial excellence. From 2021 through 2023, he was executive vice president and chief strategy and growth officer. Since joining Intuitive in 1996, Rosa has held a variety of senior leadership roles overseeing commercial, marketing, business development, and corporate development. Rosa has been a passionate supporter and evangelist of da Vinci technology since its inception.
Prior to Intuitive, Rosa contributed to the development of trans-esophageal transducers for Acuson Corporation. He serves on the board of directors’ compensation committee for Kardium, a private company based in Vancouver, Canada, that focuses on the treatment of atrial fibrillation. Rosa also serves as chairman of the board of the joint venture between Intuitive Surgical and Fosun Pharma based in Shanghai, China.
A holder of multiple patents, Rosa earned a B.S. in mechanical engineering from California Polytechnic University at San Luis Obispo, and an M.S. in mechanical engineering from Stanford University.